Respirent Pharmaceuticals Co. Ltd.

Respirent Pharmaceuticals Co. Ltd. focuses on respiratory medicine, with clinical research centred on inhaled therapies used in the regular treatment of bronchial asthma and in the maintenance management of chronic obstructive pulmonary disease (COPD). Its trial activity reflects interest in medicines that support long-term control of airflow obstruction and symptom relief in chronic airway disease.

• Bronchial asthma
• Chronic obstructive pulmonary disease (COPD)
• Airflow obstruction

The sponsor’s research landscape includes inhaled combination treatments containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA), indicating a therapeutic focus on established controller therapies for chronic respiratory conditions.